Tags (2) : Sobi
Sobi 2025 Annual & Sustainability Report: Advancing Rare Disease Therapies
03/31/2026 | Companies
annual report 2025,
biopharma,
breakthrough medicines,
corporate sustainability,
CSRD,
ESRS,
EU Taxonomy,
global biopharma,
healthcare access,
innovative therapies,
Nasdaq Stockholm,
patient care,
pharmaceutical revenue,
pipeline development,
rare disease treatments,
rare diseases,
scientific expertise,
Sobi,
sustainability report 2025,
Swedish Orphan Biovitrum,
TCFD
Most Popular Now
Environment News
Compliance
Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com


Companies